[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
December 10, 2018

Precision Medicine and Advancing Clinical Care: Insights From Iceland

Author Affiliations
  • 1Division of Cardiology, Internal Medicine Services, Landspitali–The National University Hospital of Iceland, Reykjavik
  • 2Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik
  • 3Division of Nephrology, Internal Medicine Services, Landspitali–The National University Hospital of Iceland, Reykjavik
JAMA Intern Med. 2019;179(2):139-140. doi:10.1001/jamainternmed.2018.6729

Despite an emphasis on clinical practice guidelines based on evidence from randomized clinical trials, medicine in many ways remains an inexact science. The limits of evidence-based medicine are apparent, including knowledge gaps from lack of high-quality clinical data.1 Moreover, the “one size fits all” strategy, designed for the average patient, is hampered by the biological variability that leads to heterogeneity in disease expression.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words